A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Meclizine D8 | CAS 1246816-06-7 - Request Quote

Picture of Meclizine D8

Meclizine D8

SZ CAT No:SZ-M046D01
CAS No
1246816-06-7
Mol.F.
C25H19D8ClN2
Mol.Wt.
399.0
Inv. Status
Synthesis on demand
Rel. CAS No1432062-16-2 (2HCl salt)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Meclizine D8 is chemically 1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine-2,2,3,3,5,5,6,6-d8. Meclizine D8 is supplied with detailed characterization data compliant with regulatory guideline. Meclizine D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Meclizine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1246816-06-7

Purchase 1246816-06-7

Order 1246816-06-7

Enquire 1246816-06-7

price of 1246816-06-7

1246816-06-7 Supplier

1246816-06-7 Manufacturer

1246816-06-7 Exporter

buy high quality Meclizine D8

Purchase Meclizine D8

Meclizine D8 suppliers

Meclizine D8 manufacturers

Meclizine D8 price

Order Meclizine D8

Enquire Meclizine D8

Meclizine D8 cost

Meclizine D8 Supplier

Meclizine D8 Distributor

Meclizine D8 for Method Validation

Meclizine Reference Standard

Meclizine D8 for ANDA Filing

Meclizine D8 for Forced Degradation Studies

Meclizine D8 Identification Standards

Meclizine D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,